Doctors 'Hiding Faces': India's Transgender Care Halted for 12+ Patients After Rule Change

For healthcare professionals, the Indian government's new transgender rules create an ethical and clinical dilemma: how to continue providing evidence-based gender-affirming care when the legal framework is ambiguous. With clinics suspending hormone therapy and surgeries pending clarity, patient well-being is directly jeopardized, and the doctor-patient relationship is strained by fear and paperwork.

In March 2026, the Indian government abruptly dismantled the self-identification framework that allowed transgender individuals to legally change their gender marker through a simple online application backed by a letter from a gender-affirming care provider. The new law now requires certification by a government-designated panel of doctors, but the government has yet to specify the composition, qualifications, or jurisdictional authority of these panels. This regulatory vacuum has immediately disrupted gender-affirming healthcare across the country, leaving doctors uncertain about their legal standing and patients, like 26-year-old Mehr Khan in Hyderabad, turned away from routine hormone therapy appointments. The clinic staff’s visible fear—Khan reported glimpsing 'fear on the staff’s faces' and a doctor who was 'really just hiding his face'—underscores the chilling effect of ambiguous law on medical practice.

“

This confusion ripples through the entire healthcare ecosystem, from large urban hospitals to specialized clinics like the Sabrang Clinic in Hyderabad, which is funded by Tata Trusts and now cannot offer its previously routine services.

The previous system, in place before the 2026 amendment, was designed to streamline legal gender recognition by placing trust in medical professionals. An application with a supporting letter from a surgeon or psychiatrist sufficed. This process recognized the reality that gender identity is not a matter requiring bureaucratic validation beyond clinical competence. By scrapping self-identification overnight and conditioning recognition on an undefined panel, the state has injected profound uncertainty into both administrative and clinical spheres. The government’s stated rationale—to ‘curb misuse of welfare benefits and boost safeguards’—has been met with skepticism by activists and doctors who argue that the move erects barriers to essential care while providing no clear implementation pathway.

At least a dozen transgender individuals have told Reuters that the change has directly severed their care arrangements. Clinics are suspending services, delaying surgeries, and in some cases, requiring patients to sign declarations that they are seeking treatment voluntarily—a stopgap measure that highlights how providers are scrambling to manage legal risk. Five doctors, speaking anonymously, confirmed they are proceeding with extreme caution, unsure whether continuing care could expose them to legal liability. This confusion ripples through the entire healthcare ecosystem, from large urban hospitals to specialized clinics like the Sabrang Clinic in Hyderabad, which is funded by Tata Trusts and now cannot offer its previously routine services.

Legal experts are sounding alarms. Arundhati Katju, a senior lawyer with a Supreme Court practice, captured the mood bluntly: ‘Doctors are very concerned and confused as to what kind of care they are now allowed to give.’ Her comment points to a deeper constitutional tension: the right to health, including mental health, and the recognition of gender identity as inherent to dignity and personal liberty, both of which have been affirmed by Indian courts in past rulings. The new rules potentially violate these principles by creating a bureaucratic roadblock that is currently inoperable and may discourage providers from offering any care at all. The lack of clarity about whether the panels owe responsibility to state or central authorities further compounds the legal mess, opening the door to jurisdictional disputes and constitutional challenges.

The Indian change does not occur in a vacuum; it aligns with a global conservative backlash against transgender rights, most notably in the United States, where access to gender-affirming care has recently been restricted. This international context makes the Indian law part of a broader trend that activists fear could roll back years of incremental progress. For India, a country where the Supreme Court recognized transgender rights as fundamental in the landmark NALSA judgment (2014), this regulatory shift represents a significant reversal, embedding administrative hurdles into what had been a gradually depaternalizing process.